Sedation and Reversal of Alpha 2 Adrenergic Receptors

LLOYD, Inc. has conducted extensive research on alpha 2-adrenergic receptor agonist and the reversal of the sedation with alpha 2-adrenergic receptor antagonist to increase the safety of these potent compounds.

To reference the reports of studies conducted on the use of tolazoline to reverse the sedative effects of xylazine click on the article(s) below.

Articles: